Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.70%
#2 Audiera Audiera +5.15%
#3 Wiki Cat Wiki Cat +3.90%
#4 Wibx Wibx +3.22%
#5 Quack AI Quack AI +2.73%
#6 TronBank TronBank +2.46%
#7 Status Status +2.14%
#8 Starpower Starpower +2.06%
#9 Janction Janction +1.95%
#10 Tutorial Tutorial +1.90%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Rang in Aktien #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Aktienkurs
$1.11
Marktkapitalisierung
$10.06M
Veränderung (1 Tag)
1.38%
Veränderung (1 Jahr)
-56.32%
Land
US
Handel Lisata Therapeutics, Inc. (LSTA)

Kategorie

Healthcare
Kursverlauf für Lisata Therapeutics, Inc. (LSTA)
Höchster Schlusskurs: $1.12 am 2026-08-01

Niedrigster Schlusskurs: $188.93K am 1999-03-01
Kursverlauf der Aktie von Lisata Therapeutics, Inc. von 1999 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 52.31%
2025 -28.03%
2024 3.05%
2023 -6.25%
2022 -78.23%
2021 -42.33%
2020 -36.52%
2019 -44.38%
2018 26.19%
2017 2.72%
2016 -70.04%
2015 -68.59%
2014 -44.74%
2013 2.99%
2012 11.54%
2011 -61.50%
2010 -9.12%
2009 147.46%
2008 -61.79%
2007 -75.15%
2006 19.82%
2005 -7.65%
2004 -69.11%
2003 253.51%
2002 -86.70%
2001 -26.92%
2000 -63.97%
1999 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.01%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 12.02%
BE